Alzheimer's disease and granulocyte density diversity

Area of Science:

• Neuroscience
• Immunology
• Hematology

Background:

• Alzheimer's disease (AD) is characterized by brain β-amyloid plaques and neuroinflammation.
• Emerging evidence suggests AD impacts circulating neutrophils, contrasting with extensive research on brain-based inflammation.
• This study focuses on peripheral eosinophils and neutrophils in AD patients.

Purpose of the Study:

• To investigate the density and distribution of circulating eosinophils and neutrophils in individuals with probable Alzheimer's disease.
• To compare these cell populations with those in age-matched healthy controls.

Main Methods:

• Recruitment of 39 probable AD patients and 22 healthy elderly controls.
• Separation of granulocytes from venous blood samples using linear Percoll™ density gradients.
• Quantification of eosinophil and neutrophil counts in 16 distinct density subfractions.

Main Results:

• AD patients showed significantly lower counts of granulocytes in lighter density fractions (13-15).
• Specific P-values indicated statistically significant differences for eosinophils (P = 0.03) and neutrophils (P = 0.01) in these fractions.
• These results suggest a depletion of specific granulocyte populations in the peripheral circulation of AD individuals.

Conclusions:

• Reduced circulating light granulocytes are a characteristic finding in individuals with Alzheimer's disease.
• This may indicate impaired granulocyte turnover or peripheral cell damage in AD.
• The study concludes that AD affects peripheral inflammatory cells, highlighting the importance of further research into granulocyte behavior in dementia.